(2,6-Dibromo-3-methoxyphenyl)boronic acid, 95.0%, 1g

1H-[1,2,4]OXADIAZOLO[4,3-A]QUINOXALIN-1-ONE, 95%, 10mg

anti-Alkaline Phosphatase (intestinal) mouse monoclonal, V17.1

4-Fluoro-3-methylbenzamide, 95.0%, 1g

3,4-Diaminopyridine, 98.0%, 5g

1-Methyl-1H-pyrazol-4-ylamine, 99.00%, 5g

5-Fluoro-2-iodonitrobenzene, 98.0%, 1g

4-{2-Methyl-3H-imidazo[4,5-b]pyridin-3-yl}piperidine dihydrochloride, 1g

2-(2-HYDROXYETHYLAMINO)-N-PHENYLACETAMIDE, 95.0%, 5g

2-(3-((3-Chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 100mg

N-Carbobenzoxy-L-phenylalaninol>98.0%(HPLC)5g

1-Phenylpiperidin-4-amine, 95.0%, 250mg

4-Bromo-2-fluorobiphenyl>99.0%(GC)25g